Barclays’s Foundation Medicine, Inc. FMI Stock Holding History

Barclays’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-78,100	Closed	-$10.7M	–	7658
2018 Q2	$10.7M	Buy	78,100 +77,400	+11,057%	+$7.03M	0.01%	1175
2018 Q1	$55K	Sell	700 -1,500	-68%	-$111K	﹤0.01%	5847
2017 Q4	$150K	Buy	+2,200	New	+$114K	﹤0.01%	4927
2015 Q3	–	Sell	-50,000	Closed	-$1.65M	–	7210
2015 Q2	$1.65M	Buy	+50,000	New	+$2.01M	﹤0.01%	2404

Barclays's FMI Position: Q3 2018 in Review

Barclays sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 19,628 shares — an estimated $2.68M sold.

Barclays first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $2.68M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Barclays reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Barclays sold 19,628 Foundation Medicine, Inc. shares in Q3 2018, an estimated $2.68M.
Barclays first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
Barclays's Foundation Medicine, Inc. position peaked at $2.68M in Q2 2018.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.